Skip to content
Screener

Total Equity at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$10.98B+13.0%
ITG
Integer HoldingsITGR
$1.7B+5.6%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.CTKB
$321.95M-14.7%
Edwards Lifesciences logo
Edwards LifesciencesEW
$10.33B+2.0%

Other financials

Income statement

See full
Revenue$52.6M+41.3%
Gross profit$42.2M+50.9%
Operating income-$29.5M-68.6%
Net income-$27.4M+15.4%
EPS (diluted)-$0.32+93.9%

Balance sheet

See full
Cash & equivalents$24.4M-78.7%
Total debt$26.3M
Total assets$344.0M

Cash flow

See full
Operating cash flow-$30.1M-129%
CapEx$1.9M+71.6%
Free cash flow-$32.0M-124%

Valuation

See full
Market cap$2.34B-3.7%
Enterprise value$2.35B
P/S12.3×

Profitability

See full
Gross margin78.1%+2.4pp
Operating margin-39.7%-4.8pp
Net margin-58.4%-12.1pp
FCF margin-40.1%-2.4pp

Returns & leverage

See full
Return on equity37.1%
Debt / equity0.1×
Current ratio5.6×

Where this comes from

Reported directly by Heartflow, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Heartflow, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001464521-26-000071
Line itemMarch 31, 2026December 31, 2025
Stockholders’ equity
Preferred stock, $0.001 par value; 50,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.001 par value; 250,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 86,105,290 and 85,280,597 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively8685
Additional paid-in capital1,401,4471,388,737
Accumulated other comprehensive loss(685)(425)
Accumulated deficit(1,115,130)(1,087,750)
Total stockholders’ equity285,718300,647
Total liabilities and stockholders’ equity$344,025$359,452

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Heartflow, Inc.'s total equity?
Heartflow, Inc. (HTFL) reported total equity of $285.72M in Q1 2026.
How has Heartflow, Inc.'s total equity changed year-over-year?
Heartflow, Inc.'s total equity increased by 132.1% year-over-year, from -$889M to $285.72M.
What is the long-term trend for Heartflow, Inc.'s total equity?
Over 3 years (2022 to 2025), Heartflow, Inc.'s total equity has grown at a -24.3% compound annual growth rate (CAGR), from -$693.64M to $300.65M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Heartflow, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude